Medifast outlines $270M-$300M 2026 revenue target as CEO transition and metabolic health focus drive execution
Source: SeekingAlpha
2026-02-17 18:25:39 ET
More on Medifast
- Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
- Medifast Is A Net-Net With Negative Enterprise Value
- Seeking Alpha’s Quant Rating on Medifast
- Historical earnings data for Medifast
- Financial information for Medifast
Read the full article on Seeking Alpha
For further details see:
Medifast outlines $270M–$300M 2026 revenue target as CEO transition and metabolic health focus drive execution
MEDIFAST INC
NASDAQ: MED
MED Trading
-1.67% G/L:
$10.625 Last:
108,612 Volume:
$10.73 Open:
MED Latest News
February 20, 2026 08:30:00 am
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
February 17, 2026 04:05:00 pm
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
MED Stock Data
$125,190,599
10,672,526
2.58%
34
N/A
Personal Services
Consumer Discretionary
US
Baltimore
